April 22 - 26, 2024
Seattle, Washington
May 7 - 9, 2024 (Virtual)
Symposium Supporters
2024 MRS Spring Meeting & Exhibit

Symposium SB01-Bioresponsive Nanotheranostics

This symposium will broadly cover the vibrant research field of the design and development of novel nanomaterials that can integrate therapeutic (e.g. drug/gene/radioisotope delivery, radiation, thermal/dynamic therapy, etc.) and diagnostic (e.g. noninvasive imaging, in vivo/ex vivo sensing, etc.) capabilities, in response to various cues in the biological/physiological environment (e.g. pH, redox potential, enzymes, glucose, oxygen level, biomimicry, etc.), as well as certain physical stimuli (e.g. temperature, magnetic field, ultrasound, radiation, self-assembly/disassembly, etc.).

Despite significant advances in biomedical approaches, many critical questions still remain: How to realize accurate prognosis to guide personalized/precision treatment? How to achieve desirable therapeutic efficacy while minimizing adverse systematic toxicity? How to spatiotemporally monitor drug fate and drug response for precision medicine? How to facilitate clinical translation? By harnessing the modular structure and bioresponsive properties of functional nanomaterials, nanotheranostics hold tremendous potential to provide accurate diagnostic and therapeutic capabilities, and has been a flourishing field over the last 2 decades. This 3-day symposium on “Bioresponsive Nanotheranostics” will gather the brightest minds with academic, industrial, and clinical backgrounds from various international institutes to share cutting-edge research and inspirational opinions, which will foster/catalyze exciting opportunities for (international) interdisciplinary and multidisciplinary collaborations.

Topics will include:

  • Nanotheranostics in response to biological stimuli
  • Nanotheranostics in response to physical stimuli
  • Biomimetic nanotheranostics
  • Clinical translation of nanotheranostics
  • Nanomaterials for biomedical imaging
  • Nanomaterials for new type of treatments
  • Nanomaterials as drug delivery systems
  • Preclinical and 3D models for nanomedicine

Invited Speakers:

  • Frank Caruso (The University of Melbourne, Australia)
  • Rona Chandrawati (University of New South Wales, Australia)
  • Gemma-Louise Davies (University College London, United Kingdom)
  • Stefaan De Smedt (Ghent University, Belgium)
  • Zi (Sophia) Gu (University of New South Wales, Australia)
  • Qianjun He (Shanghai Jiao Tong University, China)
  • Hao Hong (Nanjing University, China)
  • Dale Huber (Sandia National Laboratories, USA)
  • Daishun Ling (Shanghai Jiao Tong University, China)
  • Zhuang Liu (Soochow University, China)
  • Chad Mirkin (Northwestern University, USA)
  • Samir Mitragotri (Harvard University, USA)
  • Kanyi Pu (Nanyang Technological University, Singapore)
  • Stefaan Soenen (KU Leuven, Belgium)
  • Kristofer Thurecht (The University of Queensland, Australia)
  • Jiajia Xue (Beijing University of Chemical Technology, China)
  • Xiyun Yan (Institute of Biophysics, Chinese Academy of Sciences, China)
  • Chun-Xia Zhao (The University of Adelaide, Australia)
  • Yongfeng Zhao (Jackson State University, USA)

Symposium Organizers

Weibo Cai
University of Wisconsin–Madison
USA

Bella Manshian
KU Leuven
Imaging and Pathology
Belgium

Dalong Ni
Shanghai Jiao Tong University
School of Medicine
China

Ruirui Qiao
The University of Queensland
Australia

Topics

biomaterial biomimetic biomimetic (assembly) nanoscale nanostructure responsive self-assembly